Showing 1 - 20 results of 26 for search 'Mirjam J Knol', query time: 0.05s
Refine Results
-
1
-
2
Pathogen- and Type-Specific Changes in Invasive Bacterial Disease Epidemiology during the First Year of the COVID-19 Pandemic in The Netherlands by Anneke Steens, Mirjam J. Knol, Wieke Freudenburg-de Graaf, Hester E. de Melker, Arie van der Ende, Nina M. van Sorge
Published 2022-05-01
Article -
3
Assessment of hybrid population immunity to SARS-CoV-2 following breakthrough infections of distinct SARS-CoV-2 variants by the detection of antibodies to nucleoprotein by Gerco den Hartog, Stijn P. Andeweg, Christina E. Hoeve, Gaby Smits, Bettie Voordouw, Dirk Eggink, Mirjam J. Knol, Robert S. van Binnendijk
Published 2023-10-01
Article -
4
Evidence Synthesis in Harm Assessment of Medicines Using the Example of Rosiglitazone and Myocardial Infarction by Charlotte Rietbergen, Gudrun Stefansdottir, Hubert G. Leufkens, Mirjam J. Knol, Marie L. De Bruin, Marie L. De Bruin, Irene Klugkist, Irene Klugkist
Published 2018-02-01
Article -
5
European data sources for computing burden of (potential) vaccine-preventable diseases in ageing adults by Estelle Méroc, Janeri Fröberg, Timea Almasi, Brita Askeland Winje, Alejandro Orrico-Sánchez, Anneke Steens, Scott A. McDonald, Kaatje Bollaerts, Mirjam J. Knol
Published 2021-04-01
Article -
6
Timing of an adolescent booster after single primary meningococcal serogroup C conjugate immunization at young age; an intervention study among Dutch teenagers. by Susanne P Stoof, Fiona R M van der Klis, Debbie M van Rooijen, Mirjam J Knol, Elisabeth A M Sanders, Guy A M Berbers
Published 2014-01-01
Article -
7
Invasive pneumococcal disease among adults with hematological and solid organ malignancies: A population-based cohort study by Hannah M. Garcia Garrido, Mirjam J. Knol, Jarom Heijmans, Nina M. van Sorge, Elisabeth A.M. Sanders, Heinz-Josef Klümpen, Martin P. Grobusch, Abraham Goorhuis
Published 2021-05-01
Article -
8
Increased carriage of non-vaccine serotypes with low invasive disease potential four years after switching to the 10-valent pneumococcal conjugate vaccine in The Netherlands. by Marloes Vissers, Alienke J Wijmenga-Monsuur, Mirjam J Knol, Paul Badoux, Marlies A van Houten, Arie van der Ende, Elisabeth A M Sanders, Nynke Y Rots
Published 2018-01-01
Article -
9
Higher-valency pneumococcal conjugate vaccines in older adults, taking into account indirect effects from childhood vaccination: a cost-effectiveness study for the Netherlands by Pieter T. de Boer, Cornelis H. van Werkhoven, Albert Jan van Hoek, Mirjam J. Knol, Elisabeth A. M. Sanders, Jacco Wallinga, Hester E. de Melker, Anneke Steens
Published 2024-02-01
Article -
10
-
11
-
12
Dynamics and Determinants of Pneumococcal Antibodies Specific against 13 Vaccine Serotypes in the Pre-Vaccination Era. by Annemarijn C Prins-van Ginkel, Guy A M Berbers, Lucienne H Grundeken, Irina Tcherniaeva, Jelle I Wittenberns, Karin Elberse, Liesbeth Mollema, Hester E de Melker, Mirjam J Knol
Published 2016-01-01
Article -
13
Changes in (risk) behavior and HPV knowledge among Dutch girls eligible for HPV vaccination: an observational cohort study by Robine Donken, Adriana Tami, Mirjam J. Knol, Karin Lubbers, Marianne A. B. van der Sande, Hans W. Nijman, Toos Daemen, Willibrord C. M. Weijmar Schultz, Hester E. de Melker
Published 2018-07-01
Article -
14
Socioeconomic Status Is Associated With Antibody Levels Against Vaccine Preventable Diseases in the Netherlands by Joske Hoes, Anna G. C. Boef, Mirjam J. Knol, Hester E. de Melker, Liesbeth Mollema, Fiona R. M. van der Klis, Nynke Y. Rots, Debbie van Baarle, Debbie van Baarle
Published 2018-07-01
Article -
15
Direct Comparison of Immunogenicity Induced by 10- or 13-Valent Pneumococcal Conjugate Vaccine around the 11-Month Booster in Dutch Infants. by Alienke J Wijmenga-Monsuur, Els van Westen, Mirjam J Knol, Riet M C Jongerius, Marta Zancolli, David Goldblatt, Pieter G M van Gageldonk, Irina Tcherniaeva, Guy A M Berbers, Nynke Y Rots
Published 2015-01-01
Article -
16
Serotype-Specific IgG Antibody Waning after Pneumococcal Conjugate Primary Series Vaccinations with either the 10-Valent or the 13-Valent Vaccine by Els van Westen, Mirjam J. Knol, Alienke J. Wijmenga-Monsuur, Irina Tcherniaeva, Leo M. Schouls, Elisabeth A. M. Sanders, Cecile A. C. M. van Els, Guy A. M. Berbers, Nynke Y. Rots
Published 2018-12-01
Article -
17
Correction: Direct Comparison of Immunogenicity Induced by 10- or 13-Valent Pneumococcal Conjugate Vaccine around the 11-Month Booster in Dutch Infants. by Alienke J Wijmenga-Monsuur, Els van Westen, Mirjam J Knol, Riet M C Jongerius, Marta Zancolli, David Goldblatt, Pieter G M van Gageldonk, Irina Tcherniaeva, Guy A M Berbers, Nynke Y Rots
Published 2016-01-01
Article -
18
Effects of COVID-19 vaccination and previous infection on Omicron SARS-CoV-2 infection and relation with serology by Brechje de Gier, Anne J. Huiberts, Christina E. Hoeve, Gerco den Hartog, Henri van Werkhoven, Rob van Binnendijk, Susan J. M. Hahné, Hester E. de Melker, Susan van den Hof, Mirjam J. Knol
Published 2023-08-01
Article -
19
Health-related quality of life during the COVID-19 pandemic: The impact of restrictive measures using data from two Dutch population-based cohort studies by Cheyenne C. E. van Hagen, Anne J. Huiberts, Elizabeth N. Mutubuki, Hester E. de Melker, Eric R. A. Vos, Janneke H. H. M. van de Wijgert, Susan van den Hof, Mirjam J. Knol, Albert Jan van Hoek
Published 2024-01-01
Article -
20
Vaccine effectiveness of primary and booster COVID-19 vaccinations against SARS-CoV-2 infection in the Netherlands from July 12, 2021 to June 6, 2022: A prospective cohort study by Anne J. Huiberts, Brechje de Gier, Christina E. Hoeve, Hester E. de Melker, Susan J.M. Hahné, Gerco den Hartog, Diederick E. Grobbee, Janneke H.H.M. van de Wijgert, Susan van den Hof, Mirjam J. Knol
Published 2023-08-01
Article